|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology 显示文摘 | Ludovini V Pistola L Gregorc V | 2008 | J Thorac Oncol2008，3，4： | 1 |
| 2 | Plasma DNA,microsatellite alterations,and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients:a study of the perugia multidisciplinary team for thoracic oncology显示文摘 | Ludovini V Pistola L Gregorc V | 2008 | J Thorac Oncol2008，3，4： | 1 |
| 3 | Geefitinib in patients with brain metastases from non-small-cell lung cancer:a prospective trial显示文摘 | Ceresoli GL Cappuzzo F Gregorc V | 2004 | Ann Oncol2004，15，7： | 1 |
| 4 | Induction chemotherapy with gemcitabine and cisplatin in locally advanced stage Ⅲ non-small cell lung cancer: A phase Ⅱ study显示文摘 | Crino L Betti M Gregorc V | 1999 | Proc Am Soc Clin Oncol1999，18，4： | 1 |
| 5 | Phase Ⅱ study of asparagine-glycine-arginine-human tumor necrosis factor alpha,a selective vascular targeting agent,in previously treated patients with malignant pleural mesothelioma显示文摘 | Gregorc V Zucali PA Santoro A | | 0，，15： | 1 |
| 6 | Geefitinibin patients with brainmetas tasesfrom non-small-celllungcancer: aprospectivetri-al显示文摘 | Ceresoli G L Cappuzzo F Gregorc V | 2004 | Ann Oncol2004，15，7： | 1 |
| 7 | Gefitinib in patients with brain meta-stases from non-small-cell lung cancer:a prospective trial显示文摘 | Ceresoli G L Cappuzzo F Gregorc V | 2004 | Ann Oncol2004，5，7： | 1 |
| 8 | Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer显示文摘 | Ludovini V Gregorc V Pistola L | 2004 | Lung Cancer2004，46，： | 1 |
| 9 | Prognostic value of circulating chromogranin A and soluble tumor necrosis factor recePtors in advanced nonsmaU cell lung cancer 显示文摘 | Gregorc V SPreafico A Floriani I | 2007 | Cancer2007，110，4： | 1 |
| 10 | Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable stage Ⅲ A - bulky N2 and stage Ⅲ B non - small cell lung carcinoma an Italian Lung Cancer Project Observational Study 显示文摘 | Cappuzzo F Selvaggi G Gregorc V | 2003 | Cancer2003，98，1： | 1 |
| 11 | Gefitinib in patients with brain metastases from non-small cell lung cancer:a prospective trial 显示文摘 | Ceresoli GL Cappuzzo F Gregorc V | 2004 | Ann Oncol2004，15，7： | 1 |
| 12 | Influence of serum vascular endothelial growth factor (VEGF) and haemoglobin (Hb) levels on survival of non-small cell lung cancer patients (NSCLC)显示文摘 | Gregorc V Ludovini V Pistola L | 2002 | Ann Oncol2002，13，3： | 1 |
| 13 | Gefitinib in pretreated non-small-cell lung eancer(NSCLC):analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLC显示文摘 | Cappuzzo F Gregorc V Rossi E | 2003 | J Clin Oncol2003，21，14： | 1 |
| 14 | Gefitinib in pretreated non-smallcell lung cancer (NSCLC):analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locallyadvanced or metastatic NSCLC显示文摘 | Cappuzzo F Gregorc V Rossi E | 2003 | J Clin Oncol2003，21，14： | 1 |
| 15 | Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors:a multicohort cross-institutional study显示文摘 | Taguchi F Solomon B Gregorc V | 2007 | J Natl Cancer Inst2007，99，11： | 1 |
| 16 | Predictive value of a pro- teomic signature in patients with non - small - cell lung cancer treated with second- line erlotinib or chemotherapy(PROSE) :A biomarker- stratified, randomised phase 3 trial 显示文摘 | Gregorc V Novello S Lazzari C | 2014 | Lancet On- col2014，15，7： | 1 |
| 17 | Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha,a selective vascular targeting agent,in previously treated patients with malignant pleural mesotheliom显示文摘 | Gregorc V Zucali PA Santoro A | 2010 | J Clin Oneol2010，28，15： | 1 |
| 18 | Vascular endothelial growth factor,p53,Rb,Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer显示文摘 | Gregorc V Pistola L | 2004 | Lung Cancer2004，46，： | 1 |
| 19 | Combined treatment of non-small cell lung cancer with synchronous brain metastases: a single center experi- ence显示文摘 | MELLONI G BANDIERA A GREGORC V | 2011 | J Cardiovasc Surg (Torino)2011，52，4： | 1 |
| 20 | Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine ki-nase inhibitors: a multicohort cross-institutional study显示文摘 | Taguchi F Solomon B Gregorc V | 2007 | J Natl Cancer Inst2007，99，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员